Stay updated on Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 'Results First Posted (Estimated) Last Update Posted (Estimated)' has been changed to 'Results First Posted Last Update Posted'. This change likely indicates that the website now provides more accurate and precise information regarding the posting and updating of study results.
    Difference
    0.1%
    Check dated 2024-06-10T19:18:37.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value 2023-02-08 has been updated to 2024-06-07, indicating that the results were first posted on June 7, 2024, with 42 results reported. This change represents the latest update in the study record, showing progress in the reporting of results for the clinical trial.
    Difference
    3%
    Check dated 2024-06-07T16:04:23.000Z thumbnail image
  7. Check
    7 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the dose or effectiveness evaluation of poly-ICLC combined with pembrolizumab in patients with colon cancer that is unlikely to respond to pembrolizumab alone.
    Difference
    0.1%
    Check dated 2024-06-06T14:31:40.000Z thumbnail image
  8. Check
    21 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.' This change provides a more detailed explanation of the eligibility criteria for participation in the study.
    Difference
    24%
    Check dated 2024-05-22T21:25:12.000Z thumbnail image
  9. Check
    43 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:40:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page.